<DOC>
	<DOCNO>NCT01407211</DOCNO>
	<brief_summary>The aim study comparison effect supplementation vitamin A ( retinyl palmitate ) placebo 6 month gene expression T CD4+ lymphocyte multiple sclerotic patient .</brief_summary>
	<brief_title>Impact Vitamin A Gene Expression , Multiple Sclerosis Patient</brief_title>
	<detailed_description>Multiple sclerosis ( MS ) chronic inflammatory demyelinate disease central nervous system ( CNS ) .The important reason limit success obtain treatment prevention far likely related limit knowledge cause pathogenesis MS.One recent propose mechanism autoimmunity base MS Th1/Th2 implance well inflammatory anti-inflammatory T cell Th17 Treg release cytokine . Therefore control cytokine production may become potential therapeutic target modulation Th1/Th2 balance may provide new pharmacological tool treat disease . Vitamin A ( VA ) VA-like analog know retinoids , potent hormonal modifier type 1 type 2 response definitive description mechanism ( ) action lack . high level dietary vitamin A enhance Th2 cytokine production IgA responses , likely decrease Th1 cytokine production . Retinoic acid inhibits IL 12 production activate macrophage , RA pretreatment macrophage reduce IFNγ production increase IL4 production antigen prim CD4 T cell . Supplemental treatment vitamin A retinoic acid ( RA ) decrease IFNγ increase IL5 , IL10 , IL4 production . Thus , vitamin A deficiency bias immune response Th1 direction , whereas high level dietary vitamin A may bias response Th2 direction .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<criteria>Patients use interferon beta last 3 month . Patients 15 EDSS Patients diseases affect Th1/Th2 balance asthma , active viral infection , autoimmune disease , OR Patients allergy vitamin A compound , OR Patients use vitamin supplement last 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>multiple sclerosis</keyword>
	<keyword>Myelin Oligodendrocyte Glycoprotein ( MOG )</keyword>
	<keyword>Vitamin A</keyword>
	<keyword>CD4-Positive T-Lymphocytes</keyword>
	<keyword>gene expression</keyword>
	<keyword>Th1 Cells</keyword>
	<keyword>Th2 Cells</keyword>
</DOC>